Inclusion Body Myositis
What is inclusion-body myositis (IBM)?
One of the most prevalent and incapacitating inflammatory myopathies in people over 50 is inclusion body myositis (IBM). According to two modest studies from the 1980s and 1990s, 1 to nearly 8 cases of IBM is predicted to occur annually in every 1 million Americans.
Myositis is another term for inflammatory myopathy. Myositis is an inflammatory muscle condition because the roots “myo” and “itis” both refer to muscles and inflammation, respectively.
As one of the idiopathic inflammatory myopathies, IBM is grouped with polymyositis, dermatomyositis, and autoimmune necrotizing myopathy (a group of disorders characterized by inflammation of the skeletal muscle). Invading the muscular tissue, inflammatory cells gather in the spaces between the muscle fibers. An IBM patient’s biopsy reveals many inclusion bodies that contain the cellular makeup of dead tissue. The “bodies”—clumps of wasted cellular material—that gather in the muscle tissues are how IBM got its name. Surrounding these bodies are concentrated immune cells.
There are also hereditary types of IBM in which inflammation does not often play a significant role. Because of this, these variants are frequently referred to as inclusion-body myopathy (muscle disorder), omitting the word “itis” to highlight the disease’s generally low inflammatory level.